Answers are grounded in this paper and cite their sources.
Memantine plus donepezil showed superior outcomes for cognition, global assessment, daily activities, and neuropsychiatric symptoms, but lower acceptability than monotherapy and placebo. Combination therapy may be more cost-effective, because memantine slows the progression of AD.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: